BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1151979)

  • 1. Quantitative structure-activity relationships in the delta6-6-substituted progesterone series. A reappraisal.
    Topliss JG; Shapiro EL
    J Med Chem; 1975 Jun; 18(6):621-3. PubMed ID: 1151979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of 6-azido and 6-thiocyanato substitution on progestational and corticoid activities and a structure-activity correlation in the delta6-6-substituted progestational series.
    Teutsch G; Weber L; Page G; Shapiro EL; Herzog HL
    J Med Chem; 1973 Dec; 16(12):1370-6. PubMed ID: 4765863
    [No Abstract]   [Full Text] [Related]  

  • 3. A quantitative reexamination of structure-activity relationships in the delta6-6-substituted progesterone series.
    Wolff ME
    J Med Chem; 1974 Aug; 17(8):898-900. PubMed ID: 4845383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of glucocorticoid and progestational activity with steric, electronic and hydrophobic parameters.
    Wolff ME; Hansch C; Giannini DD; Kollman PA; Duax WL; Baxter J
    J Steroid Biochem; 1975; 6(3-4):211-4. PubMed ID: 171485
    [No Abstract]   [Full Text] [Related]  

  • 5. [Pregna-D'-pentaranes--progestins and antiprogestins: I. Differentiation of biological functions of steroid hormones].
    Kamernitskiĭ AV; Levina IS
    Bioorg Khim; 2005; 31(2):115-29. PubMed ID: 15889785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Relationship between chemical structure and gestagenic activity in a new series of pentacyclic analogs of progesterone--pentaranes].
    Akhrem AA; Sotskova IV; Kulikova LE; Terekhina AI; Levina IS
    Dokl Akad Nauk SSSR; 1973 Mar; 209(2):504-7. PubMed ID: 4700396
    [No Abstract]   [Full Text] [Related]  

  • 7. Quantitative structure-activity relationships among steroids. Investigations of the use of steric parameters.
    Coburn RA; Solo AJ
    J Med Chem; 1976 Jun; 19(6):748-54. PubMed ID: 950640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MTD calculations on quantitative structure-activity relationships of steroids binding to the progesterone receptor.
    Bohl M; Simon Z; Vlad A; Kaufmann G; Ponsold K
    Z Naturforsch C J Biosci; 1987; 42(7-8):935-40. PubMed ID: 2961153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural requirements for progestational activity. Synthesis and properties of rac-8alpha,9beta,10alpha,14beta-progesterone.
    Solo AJ; Kumar V; Alks V
    J Med Chem; 1979 Feb; 22(2):129-33. PubMed ID: 423192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The effect of pregna-D'-pentarans on myometrial contractile activity in pregnant rats].
    Kareva EN; Kamernitskiĭ AV; Levina LS; Solov'eva EV; Kirpichnikova NV; Isaeva SA
    Eksp Klin Farmakol; 1999; 62(5):25-7. PubMed ID: 10572747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in structure of progestins and their binding to progesterone receptors.
    Cabeza M; Heuze Y; Sánchez A; Garrido M; Bratoeff E
    J Enzyme Inhib Med Chem; 2015 Feb; 30(1):152-9. PubMed ID: 24666307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-activity relationships of a series of substituted 17alpha-hydroxy-9beta, 10alpha-progesterones.
    Hartog J; Halkes SJ; Morsink L; De Wachter AM; Schlatmann JL
    J Steroid Biochem; 1975 May; 6(5):577-83. PubMed ID: 1186243
    [No Abstract]   [Full Text] [Related]  

  • 13. Synthesis of 15-keto-6beta, 7beta-methyleneprogesterone. Effect of the 6beta, 7beta-methylene group on mineralocorticoid activity.
    Chinn LJ; Desai BN
    J Med Chem; 1975 Mar; 18(3):268-71. PubMed ID: 1133817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progesterone and progestins: effects on brain, allopregnanolone and beta-endorphin.
    Pluchino N; Luisi M; Lenzi E; Centofanti M; Begliuomini S; Freschi L; Ninni F; Genazzani AR
    J Steroid Biochem Mol Biol; 2006 Dec; 102(1-5):205-13. PubMed ID: 17052903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progesterone metabolites, effective at the GABAA receptor complex, attenuate pain sensitivity in rats.
    Frye CA; Duncan JE
    Brain Res; 1994 Apr; 643(1-2):194-203. PubMed ID: 8032914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New 11 beta-aryl-substituted steroids exhibit both progestational and antiprogestational activity.
    Rao PN; Wang Z; Cessac JW; Rosenberg RS; Jenkins DJ; Diamandis EP
    Steroids; 1998 Oct; 63(10):523-30. PubMed ID: 9800283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Synthetic progestogens versus oral progesterone].
    Alonso-Uriarte R; Cortés-Gallegos V
    Ginecol Obstet Mex; 1991 Feb; 59():50-8. PubMed ID: 2066005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The action of progestational agents on oxytocinase activity in the female rabbit hypothalamus.
    Frith DA; Hooper KC
    Acta Endocrinol (Copenh); 1972 Jul; 70(3):429-37. PubMed ID: 5068060
    [No Abstract]   [Full Text] [Related]  

  • 19. Influence of 5alpha- and 5beta-reduced progestins on the contractility of isolated human myometrium at term.
    Perusquía M; Jasso-Kamel J
    Life Sci; 2001 May; 68(26):2933-44. PubMed ID: 11411793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of a bioassay of progestational activity.
    Madjerek ZS; Smit-Vis JH
    J Endocrinol; 1975 Jul; 66(1):135-6. PubMed ID: 51896
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.